Connect with others who understand.

  •   Learn from expert-reviewed resources
  •   Real advice from people who’ve been there
  •   People who understand what you’re going through
Sign Up Log In
All Resources Treatments A-Z Personal Assistant Help Center Crisis
Powered By
Real members of MyMyelomaTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.

Have any of you been on the BiTe (bispecific T-cell engager) therapy? And how are you doing with it?

A MyMyelomaTeam Member asked a question 💭
Newton, KS
July 8, 2024
 · 
Reactions
A MyMyelomaTeam Member

My dotor told me that you should have car-t first. Bite therapy is more receptive after car-t. If you do bite first and then need car-t it is not as receptive. car-t is suppose to be the cancer killer.

July 9, 2024
MyMyelomaTeam

If you or a loved one has been on BiTE (bispecific T-cell engager) therapy for relapsed or refractory multiple myeloma (RRMM), you might find it helpful to connect with others who have similar experiences. On MyMyelomaTeam, a social network for people with multiple myeloma and their loved ones, more than 20,000 members come Show Full Answer

If you or a loved one has been on BiTE (bispecific T-cell engager) therapy for relapsed or refractory multiple myeloma (RRMM), you might find it helpful to connect with others who have similar experiences. On MyMyelomaTeam, a social network for people with multiple myeloma and their loved ones, more than 20,000 members come together to ask questions, give advice, and share their stories. This could be a great place to discuss your experiences and hear from others about how they are doing with BiTE therapy.

July 8, 2024

Related Questions

View All

I have a question about Tecvayli

A MyMyelomaTeam Member asked a question 💭
Wainaku, Hilo, Hawaii
April 25

BiTE Therapy for Myeloma: How Bispecific Antibodies Work
CAR-T Cell Therapy for Multiple Myeloma: What Is It?
33% Stay Myeloma-Free 5 Years After CAR T-Cell Therapy
Continue with Facebook
Continue with Google
By joining, you accept our Terms of Use, and acknowledge our collection, sharing, and use of your data in accordance with our Health Data and Privacy policies.
Already a member? Log In